Adjunctive Study of AL-37807 Ophthalmic Suspension

Completed · Phase 2

Conditions studied: Open-Angle Glaucoma, Ocular Hypertension

In brief

The purpose of the study is to compare the safety and intraocular pressure-lowering efficacy of AL-37807 ophthalmic suspension vs. Timolol gel forming solution vs. AL-37807 vehicle, all dosed concomitantly with Xalatan, in patients with open-angle glaucoma or ocular hypertension.

Key facts

Study ID

NCT00620256

Run by

Alcon Research

People needed

129

Starts

2007-11-01

Expected to finish

2008-07-01

Last updated by the study team

2012-12-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Open-angle glaucoma
• Ocular hypertension
• Must have been on Xalatan for at least 3 months
• VA not worse than 0.60
• Other protocol-defined inclusion criteria may apply

You may not qualify if…

• Age related
• Other protocol-defined exclusion criteria may apply

Where it is running

• Contact Alcon Call Center at 1-888-451-3937 — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.